A significant downturn swept across the Indian stock market on April 7, driven by mounting concerns over a potential trade war that could jeopardize the global economy. Investor sentiment took a hit as a broad selloff led to 734 stocks plummeting to their 52-week lows by 11 AM. Among these, six prominent Sensex stocks, including TCS, Titan, Tata Motors, Reliance, Larsen & Toubro (L&T), and Infosys, experienced severe declines.
Major Stock Declines
- Tata Motors faced the steepest drop, with its share price crashing 12% to reach ₹542.55—a notable 52-week low.
- Infosys saw its share price tumble 10%, hitting a low of ₹1,307.10.
- Larsen & Toubro shares fell 9%, reaching a yearly low of ₹2,967.65.
- TCS stocks dipped over 7%, settling at ₹3,060.25 on the BSE.
- Reliance Industries also witnessed a decline of more than 7%, hitting a low of ₹1,115.55.
- Titan Company shares decreased by over 4%, dropping to ₹2,947.55.
In addition to these Sensex giants, several other companies—including Bajaj Auto, Bharat Forge, Cipla, Dabur, DLF, Dr. Reddy’s Labs, Havells, Hero MotoCorp, Hindalco, LTIMindtree, Samvardhana Motherson International, and ONGC—also recorded their 52-week lows.
Sensex and Nifty Plummet
The selloff caused the Sensex to plunge nearly 4,000 points, while the Nifty 50 dipped below 21,750 during early trading. The BSE Midcap and Smallcap indices were particularly hard-hit, falling by up to 10%. This drastic market movement slashed the overall market capitalization of BSE-listed companies from over ₹403 lakh crore to ₹384 lakh crore, resulting in a staggering ₹19 lakh crore loss for investors in just one session.
Expert Insights
"Global markets are currently facing intense volatility due to significant uncertainty. No one can predict how the situation arising from Trump’s tariffs will unfold. In this turbulent phase, a wait-and-see approach may be prudent," remarked V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services.
He added that sectors such as financials, aviation, hospitality, select automotive, and defense are likely to remain relatively insulated from the ongoing crisis. "Given Trump’s current position, it’s improbable that tariffs will be imposed on pharmaceuticals, suggesting resilience in this segment," he concluded.
For the latest updates on the stock market and investment strategies, stay informed and connected with expert analyses.
